RHYTHM PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic from 2019 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Rhythm Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2019 to Q3 2025.
  • Rhythm Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 66.3M shares, a 8.23% increase year-over-year.
  • Rhythm Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 61M shares, a 5.76% increase from 2023.
  • Rhythm Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 57.7M shares, a 10.7% increase from 2022.
  • Rhythm Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 52.1M shares, a 5.08% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

RHYTHM PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 66.3M +5.04M +8.23% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-04
Q2 2025 63.7M +2.67M +4.38% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 63.1M +2.92M +4.85% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 61M +3.32M +5.76% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-28
Q3 2024 61.2M +3.34M +5.78% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-04
Q2 2024 61M +4.14M +7.29% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 60.1M +3.43M +6.06% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 57.7M +5.55M +10.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-28
Q3 2023 57.9M +6.47M +12.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 56.9M +6.47M +12.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 56.7M +6.38M +12.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 52.1M +2.52M +5.08% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-28
Q3 2022 51.4M +1.15M +2.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 50.4M +189K +0.38% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 50.3M +2.69M +5.64% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 49.6M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 50.2M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 50.2M +6.11M +13.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 47.6M +3.59M +8.15% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q2 2020 44.1M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 44M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03

RHYTHM PHARMACEUTICALS, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 61M +3.32M +5.76% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 57.7M +5.55M +10.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 52.1M +2.52M +5.08% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-28
2021 49.6M +5.47M +12.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 44.1M +7.7M +21.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 36.4M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.